Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
about
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BAntiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-AnalysisLamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir.Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.Long-term outcomes and dynamics of mutants associated with lamivudine-adefovir rescue therapy in patients with lamivudine-resistant chronic hepatitis B.Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysisA Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic ChemotherapyA randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol.Comparison of the efficacy of tenofovir monotherapy versus tenofovir-based combination therapy in adefovir-experienced chronic hepatitis B patients: a systematic review and meta-analysisTenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failuresOptimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy.Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance.Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosisLamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patientsAntiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort studyEfficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure.Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study.Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis BManagement of antiviral drug resistance in chronic hepatitis BHepatitis B: treatment choice and monitoring for response and resistance.Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.High dose of Lamivudine and resistance in patients with chronic hepatitis B.Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance.Entecavir plus adefovir combination therapy versus lamivudine add-on adefovir for lamivudine-resistant chronic hepatitis B: A meta-analysis.Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy.Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.
P2860
Q27030828-79079270-A6B0-4140-8D13-A12D8F91197EQ28074579-C7684EC2-2A71-4E08-A5BA-8E0BFC4347ABQ33985364-CFE571B1-9AE5-4B04-BCAF-4FBE3DDACD3DQ34339608-672E45CA-54EA-4584-9D80-AA49431AACB4Q34339613-672921D5-50BD-4F32-9B9C-5C11E519D2DAQ34471072-EF287D3B-5C10-45DE-AB2C-D6BCA8E55E99Q34809263-933605BE-8091-4207-9A9E-C1ED48F30B64Q34948124-14851AE6-DA02-4D98-9202-DC45B8D807D7Q35132805-9DF0AF4B-62DA-4FA7-A585-A48F70A48478Q35677319-0D40B173-CE79-4048-A95A-C9BABBD8CF1BQ35859123-7FB51220-9A45-4D23-B8D9-7DACEA45771FQ36492635-D3F4543A-85D9-4C83-A64C-23C0BD139133Q36492640-3893F400-5EDB-4B61-9290-5D3EAB5ABF8CQ36492959-D11F21E3-5564-40B4-8BBB-6E77F6D8E2A0Q36561590-86505331-1649-431D-A7C2-36E10DF18FD5Q36932092-62CE80D9-1F9D-4E8A-B95A-E9828BD32255Q36954038-ADD9DCB3-3D25-4DCA-BCDB-96436F6E69B4Q37229870-EABE7229-E61B-4F79-9607-D6BD6F4DD18CQ37378970-7C978844-CE53-4E59-B28B-279CB76B6161Q37564039-1B1461AE-3F39-4B16-89E2-29593E262FCAQ37573939-7C1B6026-4D0F-4DBA-A51B-55C6FA3398B1Q38132740-99C8DD67-CEA5-47F7-AF00-2A4CC4405A6DQ38247981-A76FC25E-047E-4B00-9B1D-D6A45BF02903Q38707903-DA707AA8-AC5F-4105-A315-C004A856B261Q40494788-EC7E2C91-1FD7-4F5E-8426-DAFF8E124866Q41762596-E0F12D18-D82B-4622-B5D8-5D8833103DC3Q42144275-13B70CFE-A27B-48AE-B8D0-A1F818A7D44FQ42208973-40906D44-CFDA-48D7-B5D5-B315A73CCEC7Q44911556-55E2310D-2910-4F18-8B24-B185478AF0B6Q46267580-E92C8F87-2F73-4870-B173-8A819473A869Q50190669-A51C7DA9-2DC6-4F74-AAE3-B54AAF4E3AA0Q51191468-E98FB52E-445A-488F-AAB2-82BB53AFDDA8
P2860
Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@en
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@nl
type
label
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@en
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@nl
prefLabel
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@en
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@nl
P2093
P1476
Rescue therapy for lamivudine- ...... amivudine combination therapy.
@en
P2093
Byung Ik Kim
Chong Il Sohn
Dong Il Park
Hong Joo Kim
Jung Ho Park
Woo Kyu Jeon
Yong Kyun Cho
P304
P356
10.1111/J.1440-1746.2010.06381.X
P577
2010-08-01T00:00:00Z